Análisis costo beneficio del Programa de Detección Oportuna del Cáncer Cervicouterino

Hernández-Peña, Patricia; Lazcano‐Ponce, Eduardo; Ruiz, Patricia Alonso-de; Cruz-Valdéz, Aurelio; Meneses-González, Fernando; Hernández-Ávila, Mauricio

doi:10.1590/s0036-36341997000400015

Cited by 10 publications

(13 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[1][2][3][4] Although the Pap test has helped to significantly reduce the burden of disease from cervical cancer in a number of highincome countries, as suggested by strong epidemiologic data, [5][6][7] high incidence rates and related deaths persist in many middle to low-income Latin American nations. 8,9 In some cases, these findings may be explained by the socioeconomic disparities and high levels of marginalization throughout the region. 10,11 A cytology program has large infrastructural and resource requirements.…”

Section: Objetivo Estimar El Costo Anual Del Programa Nacional De Dementioning

confidence: 99%

Cost of the Cervical Cancer Screening Program at the Mexican Social Security Institute

et al. 2014

View full text Add to dashboard Cite

Objective. To estimate the annual cost of the National Cervical Cancer Screening Program (CCSP) of the Mexican Institute of Social Security (IMSS). Materials and methods. This cost analysis examined regional coverage rates reported by IMSS. We estimated the number of cytology, colposcopy, biopsy and pathology evaluations, as well as the diagnostic test and treatment costs for cervical intraepithelial neoplasia grade II and III (CIN 2/3) and cervical cancer. Diagnostic test costs were estimated using a micro-costing technique. Sensitivity analyses were performed. Results. The cost to perform 2.7 million cytology tests was nearly 38 million dollars, which represents 26.1% of the total program cost (145.4 million). False negatives account for nearly 43% of the program costs. Conclusion. The low sensitivity of the cytology test generates high rates of false negatives, which results in high institutional costs from the treatment of undetected cervical cancer cases.

show abstract

Section: Objetivo Estimar El Costo Anual Del Programa Nacional De Dementioning

confidence: 99%

Cost of the Cervical Cancer Screening Program at the Mexican Social Security Institute

et al. 2014

View full text Add to dashboard Cite

show abstract

“…Esto confirma los resultados del estudio de Hernández, 14 en el que el total de los costos de la toma, traslado, tinción e interpretación y entrega de resultados en la SSA es muy similar. Hernández reportó, en 1997, como costo total 11.56 USD y el resultado obtenido en este estudio es de 12 USD.…”

Section: Discussionunclassified

“…[12][13][14] Así como la Secretaría de Salud (SSA) considera a la mortalidad por CaCu como uno de los problemas prioritarios de la salud pública de México, existen otras organizaciones que no pertenecen al gobierno (ONGs) que, conscientes de este problema, han puesto en marcha programas propios de detección oportuna de este tipo de cáncer dentro del marco de programas de salud dirigidos a la mujer. Uno de los grupos pioneros en este sentido es CIDHAL (Comunicación, Intercambio y Desarrollo Humano en América Latina), una ONG ubicada en Cuernavaca, Morelos, que cuenta con una programa de detección oportuna de CaCu.…”

Section: Julio-agosto De 2001unclassified

Costos y calidad de la prueba de detección oportuna del cáncer cervicouterino en una clínica pública y en una organización no gubernamental

Gómez-Jauregui¹

2001

Salud pública Méx

View full text Add to dashboard Cite

“…This is supported by the lower cervical cancer mortality in North America, which is characterised by having well organised screening programmes (Robles et al , 1996). An essential factor to guarantee the effectiveness of these programmes is the adequate coverage of the target population (Hernández‐Peña et al ., 1997; Jenkins et al ., 1994; Herrero et al ., 1992; Swaddiwudhipong et al ., 1995; Nathoo et al, 1988; Hakama et al ., 1985). The Mexican Social Security Institute programme coverage is less than 21%.…”

mentioning

confidence: 99%

“…For that purpose, multiple strategies have been suggested (Pontén et al ., 1995). Individual invitation, either by telephone or by mail, has been an effective recruitment mechanism in other countries (Hernández‐Peña et al ., 1997; Shroff et al ., 1988; Pierce et al ., 1989).…”

mentioning

confidence: 99%

Call and recall for cervical cancer screening in a developing country: A randomised field trial

et al. 2000

View full text Add to dashboard Cite

A randomised field trial was used to assess Mexican women's response to a mailed invitation for a Papanicolaou test. A sample of 4,802 women, 20 to 64 years old, chosen at random from the Mexican Social Security Institute Register were randomly assigned to an intervention and to a control group. A letter of invitation and a reminder were sent to the intervention group. A letter was also sent to the control group at the end of the follow‐up period (8.5 weeks) in order to compare the response among women who received a letter in both groups. Cumulative incidence and incidence rates were used to determine the response and the speed of response, respectively. The response among women who had received the letter was 33.5% (efficacy) in the intervention group, while 5.9% (p<0.001) in the control group attended a Papanicolaou test. For the total of women invited, the response was 20.1% (effectiveness) and 3.3% (p<0.001), respectively. The response was greater in rural areas (rural vs. urban/suburban; p = 0.002) and eldest women (50–64 vs. 20–49; p = 0.02). The response rate was 7 times grater in the intervention than in the control group (RR = 7.1; 95% CI 5.4–9.4; p < 0.001). A mailed invitation to have a Papanicolaou test substantially increases attendance by women who receive it. A mailed reminder improves results. This strategy could be implemented in addition to the ones already in use, mainly among rural and elderly women. Int. J. Cancer 87:869–873, 2000. © 2000 Wiley‐Liss, Inc.

show abstract

Análisis costo beneficio del Programa de Detección Oportuna del Cáncer Cervicouterino

Cited by 10 publications

References 10 publications

Cost of the Cervical Cancer Screening Program at the Mexican Social Security Institute

Cost of the Cervical Cancer Screening Program at the Mexican Social Security Institute

Costos y calidad de la prueba de detección oportuna del cáncer cervicouterino en una clínica pública y en una organización no gubernamental

Call and recall for cervical cancer screening in a developing country: A randomised field trial

Contact Info

Product

Resources

About